JPRN-UMIN000005254尚未招募未知
Subtenon injection of bevacizumab for retinal vein occulusion - Subtenon injection of bevacizumab for retinal vein occulusion
Department of Ophthalmology, Keio University School of Medicine0 个研究点目标入组 40 人开始时间: 2011年3月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Post vitrectomy
研究者
相似试验
尚未招募
2 期
Role of subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after cornea TransplantCTRI/2021/10/037416SNMedical College
已完成
不适用
The intravitreal injection of Bevacizumab for retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000028770Department of Ophthalmology, Shiga University of Medical Science24
已完成
不适用
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
尚未招募
不适用
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurityJPRN-UMIN000007465Tokushima university hospital10
已完成
不适用
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30